Tag: Renal Cancer

Subcutaneous nivolumab may benefit patients across many indications

Expert
Dr Saby George, Roswell Park Cancer Institute, Buffalo, NY, USA
Trial
Phase 3, CheckMate 67T
Conference
ASCO GU 2024

17 July 2024 12:37

KEYNOTE-564: Updated results of adjuvant pembrolizumab in RCC

Presented By
Prof. Thomas Powles, Barts Cancer Institute, UK
Trial
Phase 3, KEYNOTE-564
Conference
EAU 2022
Type
News article

22 July 2022 12:22

Fewer complications with robotic surgery in renal cancer

Presented By
Prof. Marc-Oliver Grimm, Universitätsklinikum Jena, Germany
Trial
Phase 3, OpeRa
Conference
EAU 2022
Type
News article

22 July 2022 12:19

Superior clinical outcomes and QoL with nivolumab plus cabozantinib in RCC

Presented By
Prof. David Cella, Robert H. Lurie Comprehensive Cancer Centre, Northwestern University, Illinois, USA
Trial
Phase 3, CheckMate 9ER
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

Lenvatinib plus pembrolizumab prolongs survival in renal cell carcinoma

Presented By
Dr Robert Motzer, Memorial Sloan Kettering Cancer Centre, New York, USA
Trial
Phase 3, CLEAR
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

Inflammatory markers may guide treatment decisions in metastatic renal cell cancer

Presented By
Ms Vishwani Chauhan, University of Edinburgh, UK
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

Clinical trial exclusion criteria may lead to lack of evidence in real-world patients: how do the excluded fare?

Presented By
Dr Diana Maslov, Ochsner Health System, Louisiana, USA
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

Axitinib offers hope for improving renal cell cancer surgical outcomes

Presented By
Prof. Grant Stewart, University of Cambridge, UK
Trial
Phase 2, NAXIVA
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

Cabozantinib as possible new first-line therapy in translocation renal cell carcinoma

Presented By
Dr Jonathan Thouvenin, Institut de Cancerologie Strasbourg Europe, France
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:52

Predictors of oral anti-cancer agent utilisation in renal cell carcinoma

Presented By
Prof. Stephanie Wheeler, University of North Carolina, USA
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:52

Denosumab plus pembrolizumab in advanced clear cell renal cell carcinoma

Presented By
Dr Craig Gedye, Calvary Mater Newcastle, Australia
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:52

Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses

Presented By
Prof. F. Porpiglia, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Italy
Conference
EAU 2020

16 September 2020 15:55
Imaging guided surgery with augmented reality for robotic partial nephrectomy.

Imaging guided surgery with augmented reality for robotic partial nephrectomy

Presented By
Prof. R. Schiavina, Sant'Orsola-Malpighi Hospital, Italy
Conference
EAU 2020

16 September 2020 15:49

KEYNOTE-426: no QoL differences pembrolizumab + axitinib versus sunitinib

Presented By
Prof. Jens Bedke, University of Tübingen, Germany
Trial
Phase 3, KEYNOTE-426
Conference
EAU 2020
Type
Peer-reviewed article

20 August 2020 10:41

Robotic-assisted partial nephrectomy: lower morbidity

Presented By
Dr Alessandro Larcher, Ospedale San Raffaele, Italy
Trial
IRON
Conference
EAU 2020
Type
Peer-reviewed article

20 August 2020 09:22

Novel mode of action for kidney cancer treatment

Presented By
Prof. Eric Jonasch, MD Anderson Cancer Center, Houston, USA
Conference
ESMO 2019
Type
Peer-reviewed article

26 November 2019 14:24

Classification of metastatic renal cell carcinoma patients in immunotherapy era and positive responses for sarcomatoid tumours

Presented By
Prof. Bernhard Escudier, Gustave Roussy Cancer Campus, Paris, France
Trial
CheckMate 214
Conference
ASCO 2019
Type
Peer-reviewed article

15 July 2019 12:49
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com